Literature DB >> 11400895

Treatment of lateral epicondylitis of the elbow with shock waves.

J Y Ko1, H S Chen, L M Chen.   

Abstract

In a prospective clinical study, the effectiveness of shock wave treatment for lateral epicondylitis in 56 elbows in 53 patients (27 men and 26 women) with an average age of 46 years was investigated. Three patients received treatment for both elbows. Each elbow was treated with 1,000 impulses of shock waves at 14 kV. A 100-point scoring system was used for evaluation including 40 points for pain, 30 points for function, 20 points for strength, and 10 points for elbow motion. The intensity of pain was measured using a visual analogue scale from 0 to 10. The overall results were 13.2% excellent, 44.7% good, 36.8% acceptable, and 5.3 unchanged in 35 patients with 12 weeks followup; 30.8% excellent, 42.3% good, and 26.9% acceptable in 25 patients with 24 weeks followup. Considerable improvement was observed from 6 weeks to 6 months after the treatment. None of the patients' symptoms became worse. The results of nine patients who also received a second treatment were good in three patients, acceptable in five patients, and unchanged in one patient. There was no device-related problems, systemic, or local complications. Shock wave therapy may offer a new and safer nonoperative treatment for patients with lateral epidoncylitis of the elbow.

Entities:  

Mesh:

Year:  2001        PMID: 11400895     DOI: 10.1097/00003086-200106000-00008

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  Extracorporeal shock wave therapy is not useful after arthroscopic rotator cuff repair.

Authors:  Jae Yoon Kim; Jae Sung Lee; Chi Woo Park
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-02-21       Impact factor: 4.342

2.  Resistant tennis elbow: shock-wave therapy versus percutaneous tenotomy.

Authors:  Yasser A Radwan; Gamal ElSobhi; Walid S Badawy; Ali Reda; Sherif Khalid
Journal:  Int Orthop       Date:  2007-06-06       Impact factor: 3.075

Review 3.  Extracorporeal shockwave therapy for the treatment of chronic wound of lower extremity: current perspective and systematic review.

Authors:  Mohammed Ta Omar; Rehab Fm Gwada; Afaf Am Shaheen; Raoul Saggini
Journal:  Int Wound J       Date:  2017-02-15       Impact factor: 3.315

4.  Is posterior synovial plica excision necessary for refractory lateral epicondylitis of the elbow?

Authors:  In Hyeok Rhyou; Kang Wook Kim
Journal:  Clin Orthop Relat Res       Date:  2012-09-11       Impact factor: 4.176

Review 5.  Chronic tendinopathy: effectiveness of eccentric exercise.

Authors:  Brett L Woodley; Richard J Newsham-West; G David Baxter
Journal:  Br J Sports Med       Date:  2006-10-24       Impact factor: 13.800

6.  Comparison of low level laser therapy and extracorporeal shock wave in treatment of chronic lateral epicondylitis.

Authors:  Türkan Turgay; Pınar Günel Karadeniz; Gökhan Bülent Sever
Journal:  Acta Orthop Traumatol Turc       Date:  2020-11       Impact factor: 1.511

7.  EXTRACORPOREAL SHOCKWAVE TERAPY TO TREAT CHRONIC MUSCLE INJURY.

Authors:  Diego Costa Astur; Bruno Santos; Eduardo Ramalho de Moraes; Gustavo Gonçalves Arliani; Paulo Roberto Dias Dos Santos; Alberto de Castro Pochini
Journal:  Acta Ortop Bras       Date:  2015 Sep-Oct       Impact factor: 0.513

8.  Medium-energy shock wave therapy in the treatment of rotator cuff calcifying tendinitis.

Authors:  Biagio Moretti; Raffaele Garofalo; Stefania Genco; Vittorio Patella; Elyazid Mouhsine
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-03-30       Impact factor: 4.342

9.  Effects of extracorporal shock wave therapy on symptomatic heel spurs: a correlation between clinical outcome and radiologic changes.

Authors:  E Yalcin; A Keskin Akca; B Selcuk; A Kurtaran; M Akyuz
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

Review 10.  Extracorporeal shockwave therapy: a review.

Authors:  Bryan Chung; J Preston Wiley
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.